Indo Borax & Chemicals Q1 FY27 Results: Net Sales ₹223.99 Lakhs
Indo Borax & Chemicals reported unaudited results for Q1 FY27. Net sales were ₹223.99 Lakhs, up from ₹119.40 Lakhs in Q1 FY26. Net profit after tax was ₹7.39 Lakhs, down from ₹17.45 Lakhs year-on-year. Basic and diluted EPS stood at ₹0.05.
The financial results show a decline in profitability despite an increase in sales, which may have a limited impact on investor sentiment due to the company's overall market position and the nature of the results.
The results show an increase in net sales compared to the previous year's quarter, but a significant decrease in net profit. This mixed performance leads to a neutral sentiment.
Indo Borax & Chemicals Limited has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported Net Sales / Total Income from Operations of ₹223.99 Lakhs for the quarter. This compares to ₹208.67 Lakhs in the previous quarter (March 31, 2026) and ₹119.40 Lakhs in the corresponding quarter of the previous year (June 30, 2025).
The Net Profit after tax and after exceptional items for the quarter stood at ₹7.39 Lakhs. This is a decrease from ₹58.27 Lakhs in the previous quarter and ₹17.45 Lakhs in the same quarter last year.
Basic and diluted Earnings Per Share (EPS) after Extraordinary items for the period was ₹0.05, down from ₹0.36 in the previous quarter and ₹0.11 in the same quarter last year.
The company's Board of Directors approved these results on August 10, 2026, following a review by the Audit Committee. The financial results have been published in the Free Press Journal and Navshakti newspapers on August 11, 2026, and are also available on the stock exchanges' websites and the company's website.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.